𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Temozolomide With or Without Radiotherapy in Melanoma With Unresectable Brain Metastases

✍ Scribed by Maja Hofmann; Felix Kiecker; Reinhard Wurm; Lorenz Schlenger; Volker Budach; Wolfram Sterry; Uwe Trefzer

Book ID
106480321
Publisher
Springer US
Year
2005
Tongue
English
Weight
176 KB
Volume
76
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Biochemotherapy of metastatic melanoma i
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases
✍ Martin Majer; Randy L. Jensen; Dennis C. Shrieve; Gordon A. Watson; Michael Wang πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract ## BACKGROUND. Brain metastases are an alarming complication of advanced melanoma, frequently contributing to patient demise. The authors performed a retrospective analysis to determine whether the treatment of metastatic melanoma with biochemotherapy would result in similar outcomes i

Temozolomide plus thalidomide in patient
Temozolomide plus thalidomide in patients with brain metastases from melanoma : A Phase II study
✍ Wen-Jen Hwu; Eric Lis; Jennifer H. Menell; Katherine S. Panageas; Lynne A. Lamb; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract ## BACKGROUND Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapy‐naive patients with brain metastases. ## METHODS Patients with